STATCenter·
STAT+: Enliven Therapeutics’ leukemia drug shows promise in new study
A targeted drug from Enliven Therapeutics induced molecular responses in nearly half of patients with advanced leukemia, new data show.
Read at STAT →
Health · 1 sources covering this
STAT+: Enliven Therapeutics’ leukemia drug shows promise in new study
A targeted drug from Enliven Therapeutics induced molecular responses in nearly half of patients with advanced leukemia, new data show.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/44f271933731cbc42021ccc6f0336ed0579f60a6" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Enliven Therapeutics’ leukemia drug shows promise in new study"></iframe>
